SERS Determination of the Antihypertensive Drugs Prazosin and Losartan by Using Silver Nanoparticles Coated with Β-Cyclodextrin

Jiawei Wu,Hao Ma,Xiangfeng Bu,Chao Ma,Lin Zhu,Baoqin Hao,Bing Zhao,Yuan Tian
DOI: https://doi.org/10.1007/s00604-019-3946-z
2019-01-01
Mikrochimica Acta
Abstract:A surface-enhanced Raman scattering (SERS) method is described for the determination of prazosin (PRH) and losartan (LOS). Silver nanoparticles modified with β-cyclodextrin (CD-S-Ag NPs) were prepared and serve as a sensitive SERS substrate. β-CD is both a reductant for silver ions and a host molecule that binds the analytes which leads to strong SERS enhancement. The method has distinct features: (a) The linear response extends from 0.1 to 60 μM for PRH, and from 1.0 to 100 μM for LOS; (b) the respective limits of detection are as low as 15 nM and 0.92 μM; and (c) the specific SERS bands of PRH and LOS are located at 703 and 1298 cm−1 respectively. The method was successfully applied to the determination of PRH and LOS illegally added to healthcare products. The recovery of PRH and LOS from spiked samples ranges between 91.3 and 109.3%, and from 87.4 to 105.2%, respectively, both with relative standard deviation of <5%.
What problem does this paper attempt to address?